A leading article in the Lancet (1967) emphasized the continuing need to maintain serological supervision of pregnant women, and that advice still holds good. Wherever and whenever antenatal serological tests for syphilis are carried out routinely, the incidence of congenital syphilis falls and remains low. The incidence of congenital syphilis in the first year of life, as reported in Great Britain, has remained low for about 20 years, but some such cases are still diagnosed annually. Most of these are due to the fecklessness of the mothers concerned, who have not availed themselves of antenatal care, but others occur because of the low index of suspicion of the clinicians in charge of that care.
Since the introduction of specific serological tests, using Treponema pallidum as an antigen, biological false positive (BFP) reactions can be detected, and pregnant women in whom they are found can be spared an erroneous diagnosis, with all its social consequences, and unnecessary treatment. According to Wilkinson (1970) , those classed as acute BFP reactions are not thought to have any adverse significance apart from the diagnostic problems they pose. Some of the serological tests used in the screening of pregnant women for syphilis have continued in use over many years, such as the various Wassermann reactions and Kahn tests, and this suggests that there is a need for a reappraisal of the tests in current use. This paper reports on the sensitivity and specificity of the various serological tests for syphilis used in the screening of pregnant women in Glasgow in a 3-year period, [1969] [1970] [1971] .
Material and methods
Since 1964 all the laboratories which carry out screening tests for syphilis on 
Results
During the 3-year period, sera from 64,404 pregnant women were examined, 285 (442-5 per 100,000) were reactive but syphilis was confirmed only in 39 (13-7 per cent.) or 60-6 per 100,000. Table II ), but the VDRL test of the latter two laboratories. In 1969, using the Kahn test, the missed 8-0 per 100,000 cases of syphilis and a similar diagnostic rate of syphilis was 42-4 per 100,000.
incidence might well have been missed by these two Because they used only one test it is impossible to laboratories. This would have amounted to at least know how many cases of syphilis they missed, but the one case of syphilis. '25 of the 37,452 sera were from patients with confirmed syphilis (66-7/100,000) b5 of the 4,808 sera were from patients with confirmed syphilis (104 0/100,000) The 'battery' of tests revealed reactive sera from 112 pregnant women (299 per 100,000). Table IV shows which of the tests, or combination of tests, were reactive in the 25 later confirmed to have syphilis and the 87 found to have BFP reactions. All three tests were reactive in 12 out of the 25 cases of syphilis, but were also positive in one further case where the results were confirmed to be a BFP reaction by repeated negative results of the TPI and FTA-ABS tests. Whenever the RPCF test was one of the two tests reported reactive, no BFP reaction was found, but these were common when the two reagin tests were reactive. When single tests only were reported reactive the VDRL was more sensitive, but less specific than the RPCF, although in two cases positive reactions of the latter were not confirmed. Whenever the WRs alone were reported reactive, it was always because of a BFP reaction. Lack of sensitivity of the combinations of tests, save that of the VDRL with the RPCF, and of each individual test is shown by the number of negative reactions in the presence of syphilis. The rating of individual tests is set out in Table V , taking as the prime criterion of a screening test its sensitivity. Thus, the VDRL, with a sensitivity of 88 per cent., was the best test. The difference between the RPCF test and the WRs, equal in regard to sensitivity, lay in the better specificity of the former which wvas rated second. The WRs, which were even less specific than the VDRL, were rated third. All three centres using the VDRL test (Glasgow, Bristol, and Helsinki) had similar rates for reactive sera, but, because of a BFP reaction rate double that of the others, the tests carried out in Glasgow appeared to be much more sensitive. The rates per 100,000 of those confirmed to be due to syphilis were lower in Glasgow than elsewhere not only for the VDRL but for all the tests. From this it would appear that the incidence of syphilis among pregnant women in Glasgow was lower than in the other centres.
The most sensitive test used in Glasgow was the VDRL, but in Bristol it was the RPCF test. There were marked differences in the specificity of the RPCF test as carried out in the two cities, the BFP rate in Glasgow (8-0 per 100,000) being the lowest of the three tests, while in Bristol (103-0 per 100,000) it was the highest. This latter result might seem surprising for a test which uses a treponemal group antigen, but Sequeira (1962) reported that the incidence of BFP reactions was 1 in 500 for the RPCF test compared with 1 in 1,000 for the standard WR. From these results he calculated that, as the antigens were independent, a BFP reaction to both tests would coincide only once in every 500,000 tests.
The CWR as used on Bristol was less sensitive than the WRs used in Glasgow, but in both series they picked up fewer confirmed cases than did either of the other tests. In Glasgow, the WRs were also the least specific of the tests, the BFP rate being 175 -8 per 100,000, similar to that of 190 per 100,000 reported by Quaife and Gostling (1971) The results of the present investigation have indicated that, of the 'battery' of tests used in Glasgow, the WRs were of no value, in that none of the sera reactive in those tests alone was confirmed as positive. In fact, the use of the WRs merely increased by 47 (117-5 per cent.) the number of reactive sera requiring investigation by the FTA-ABS and/or TPI tests to diagnose them as BI P reactions. The same conclusions can be drawn from the results reported by Morris (1968) . The CWR he used never, on its own, produced a reaction which was later confirmed as due to treponemal infection, but it did add a further 26 (41 per cent.) reactive sera from individual pregnant women which required further investigation to diagnose them as BFP reactions. In Morris's series, the VDRL and RPCF tests together had a sensitivity of 100 per cent. (they did not miss any case later confirmed as a case of treponemal disease), and a specificity of 39 7 per cent. These results are almost identical to those obtained in Glasgow, where the same two tests were 100 per cent. sensitive and 38 5 per cent. specific, even when the results of three laboratories were combined.
If the VDRL and RPCF tests together are sufficient for the serological screening for syphilis in pregnant women, then they might well be the optimum combination of tests for screening of other groups within the community.
At pre3ent, too many laboratories are testing too few sera and using a wide variety of serological (usually 'reagin') tests. A number of them lack the backing of a major clinic for the sexually transmitted diseases to provide a constant source of sera from patients with syphilis, so that, all in all, the results tend to lack consistency and reliability.
Although found worthless in the 'battery' of tests carried out in Glasgow and Bristol, WRs (or 'complement-fixation tests using lipid antigens'), were the most common serological tests in use among the 68 laboratories from throughout Great Britain which provided information to the British Cooperative Clinical Group (1972 So much for the serological tests in current use. However, the time is upon us when we must accept that the more recently developed specific tests, using T. pallidum as an antigen, have superseded, in sensitivity and specificity, the traditional 'reagin' tests and the RPCF test, and these newer tests should be used in all screening procedures, as soon as a nationwide specialist laboratory service can be set up.
Rationalization of the serological services with centralization of effort is required, now it has been established that automation of serological tests for syphilis is a practical proposition. A few specialized laboratories, each to serve a large area, should be recognized and suitably funded to set up automated serological techniques, the results of which would be consistently sensitive and specific. This would be of benefit to the community in general and to patients and staff of the clinics for sexually transmitted diseases in particular.
Of the specific tests the TPI cannot be automated and the FTA-ABS only to the point of reading the results by darkground fluorescence microscopy. This puts a severe strain on the eyes of the microscopist who has to take rests away from the microscope every so often throughout the day. On espere que dans un proche futur le depistage serologique, pour eliminer ou trouver une syphilis, sera pratique seulement dans un petit nombre de laboratoires specialises pour tout le pays qui, tous, utiliseront un test automatise avec le T. pallidum comme antigene, tel que la micro-hemagglutination du TP automatisee (AMHA (TP) ) pour eliminer le probleme des reactions biologiques faussement positives aussi bien que pour decouvrir les cas non decouverts par les tests de reagine ou le RPCF. Un budget gouvernemental devra etre accorde a des laboratoires specialises choisis, pour organiser et faire fonctionner un service centralise. Le gain de confiance obtenu tant pour la sensibilite que pour la specificite beneficiera a la communaute toute entiere mais, plus specialement, aux malades et au personnel des cliniques pour les maladies sexuellement transmises.
